Michele Tagliati, MD
Director, Movement Disorders Program
Michele Tagliati, MD, is Director of the Movement Disorders Program in the Department of Neurology at Cedars-Sinai Medical Center. Dr. Tagliati is one of the world’s pioneers in deep brain stimulation (DBS) and is an authority on the use of botulinum toxin injection therapy in the control of involuntary muscle contractions.
Dr. Tagliati previously served as Division Chief of Movement Disorders at Mount Sinai Medical Center in New York. He specializes in all forms of movement disorders, including tremor, dystonia, chorea, tics and Parkinson’s disease.
He often serves in leadership and advisory roles with such organizations as the American Academy of Neurology, the Movement Disorder Society, the National Institutes of Health, the Parkinson Study Group, the National Parkinson Foundation, the Dystonia Medical Research Foundation, the Bachmann-Strauss Dystonia & Parkinson Foundation and the Parkinson Alliance. Dr. Tagliati has lectured internationally on deep brain stimulation management and currently serves as director of the educational course on DBS programming at the American Academy of Neurology annual meetings.
The author of more than 60 articles in peer-reviewed publications, Dr. Tagliati has written more than 20 chapters in medical textbooks. He also co-authored the book “Parkinson’s Disease for Dummies,”and is currently a member of the editorial board of Movement Disorders.
Dr. Tagliati earned his medical degree from the University of Rome, Italy, where he also completed a residency in neurology and a fellowship in clinical neurophysiology. He completed an internship and second neurology residency at Mount Sinai. He then completed a fellowship in movement disorders at Beth Israel Medical Center in New York.